share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

艾伯维公司 | 25-NSE：由交易所申报的注销已到期、已赎回、已兑付证券的通知
美股sec公告 ·  05/17 09:07
Moomoo AI 已提取核心信息
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of GRI BIO, Inc. This action is set to take place at the start of business on May 28, 2024, in accordance with Rule 12d2-2(a). The notification follows the redemption or full payment of the securities at maturity or retirement, which occurred on May 17, 2024. Consequently, trading of GRI BIO, Inc.'s securities was suspended on the NYSE as of May 17, 2024.
纽约证券交易所（NYSE）已正式通知美国证券交易委员会（SEC），它打算将GRI BIO, Inc.的全部类别证券除名。根据规则12d2-2 (a)，该行动定于2024年5月28日开始营业时进行。该通知是在2024年5月17日到期或退休时赎回或全额支付证券之后发出的。因此，GRI BIO, Inc.的交易s证券自2024年5月17日起在纽约证券交易所暂停发行。
纽约证券交易所（NYSE）已正式通知美国证券交易委员会（SEC），它打算将GRI BIO, Inc.的全部类别证券除名。根据规则12d2-2 (a)，该行动定于2024年5月28日开始营业时进行。该通知是在2024年5月17日到期或退休时赎回或全额支付证券之后发出的。因此，GRI BIO, Inc.的交易s证券自2024年5月17日起在纽约证券交易所暂停发行。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息